NMTC News and Press, NeuroOne Medical Technologies Corporation From 12/11/23

First FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control; Marks the Company’s third FDA 510(k)-cleared device Potential for transformative improvement in neurosurge...

EDEN PRAIRIE, Minn., Dec. 07, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a confe...

2023-12-05 08:22:20 ET Volato Group  ( SOAR ) +78% Gitlab ( GTLB ) +14% Q3 earnings call release Travere Therapeutics ( TVTX ) +14% to seek FDA approval for Filspari in IgAN but not FSGS. NeuroOne Medical Technologies  ( NMTC ) +13% . ...

Patent allowance strengthens IP portfolio and positions company in pursuing drug delivery using its neural probes EDEN PRAIRIE, Minn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company f...

2023-11-14 17:25:32 ET More on NeuroOne Medical Technologies NeuroOne: A Hidden Contender Against ClearPoint In The Brain Drug Delivery Arena Seeking Alpha’s Quant Rating on NeuroOne Medical Technologies Historical earnings data for NeuroOne Medical Technologi...

Volker strengthens existing management team in areas of commercialization, business development, and reimbursement EDEN PRAIRIE, Minn., Nov. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company ...

2023-11-14 08:00:00 ET Summary Both NeuroOne and ClearPoint Neuro are emerging as significant players in the neurological device sector, each carving out their own niche, with ClearPoint focusing on drug delivery and NeuroOne advancing. NeuroOne is rapidly positioning itself as a ...

Feedback from responses to FDA anticipated in 30 days Commercialization remains on track in first half of 2024 pending FDA clearance Product potential for transformative improvement in neurosurgery as first known sEEG-guided RF system that records and ablates nervous tis...

EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced t...

EDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced ...